X-154460238-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017514.5(PLXNA3):c.55G>A(p.Gly19Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,208,510 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 50 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017514.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXNA3 | NM_017514.5 | c.55G>A | p.Gly19Ser | missense_variant | 2/33 | ENST00000369682.4 | NP_059984.3 | |
PLXNA3 | XM_047442247.1 | c.55G>A | p.Gly19Ser | missense_variant | 2/22 | XP_047298203.1 | ||
PLXNA3 | XR_007068193.1 | n.230G>A | non_coding_transcript_exon_variant | 2/32 | ||||
PLXNA3 | XR_430556.4 | n.230G>A | non_coding_transcript_exon_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXNA3 | ENST00000369682.4 | c.55G>A | p.Gly19Ser | missense_variant | 2/33 | 1 | NM_017514.5 | ENSP00000358696.3 | ||
PLXNA3 | ENST00000495040.1 | n.146-861G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000801 AC: 9AN: 112420Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 34586
GnomAD3 exomes AF: 0.0000778 AC: 14AN: 179866Hom.: 0 AF XY: 0.0000152 AC XY: 1AN XY: 65880
GnomAD4 exome AF: 0.000153 AC: 168AN: 1096036Hom.: 0 Cov.: 31 AF XY: 0.000138 AC XY: 50AN XY: 362078
GnomAD4 genome AF: 0.0000800 AC: 9AN: 112474Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 34650
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.55G>A (p.G19S) alteration is located in exon 2 (coding exon 1) of the PLXNA3 gene. This alteration results from a G to A substitution at nucleotide position 55, causing the glycine (G) at amino acid position 19 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PLXNA3-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 03, 2024 | The PLXNA3 c.55G>A variant is predicted to result in the amino acid substitution p.Gly19Ser. To our knowledge, this variant has not been reported in the literature. The c.55G>A variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one hemizygote, in gnomAD v2 (as displayed in the table above). However, in gnomAD v4.1 (available only on GRCh38), while it occurs at a similar allele frequency of 0.019% in the same population, the whole dataset includes 50 hemizygotes for this variant. This data is not consistent with this variant being a primary cause of disease. Although we suspect that this variant may be benign, the clinical significance of this variant is classified as uncertain at this time due to insufficient functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at